Abata in the News Harnessing regulatory T cells to establish immune tolerence Science Translational Medicine March 13, 2024 Preclinical Development of a T Cell Receptor Engineered Regulatory T Cell (Treg) Therapy for Progressive Pathology in MS ACTRIMS 2024 Poster February 29, 2024 Functional Characterization of Regulatory T cell (Treg) Therapy for the Treatment of Type 1 Diabetes (T1D) nPOD 2024 Poster February 19, 2024 Unveiling Novel T-cell Receptors (TCRs) for Enhanced Treg Cell Therapy in Type 1 Diabetes (T1D) nPOD 2024 Poster February 19, 2024 Are Cellular Therapies the Future of Autoimmune Disease? Medscape October 23, 2023 Abata Therapeutics to Present and Participate in Upcoming Investor and Industry Events Press Release August 28, 2023 Abata Therapeutics to Present at Upcoming Investor and Industry Events in June Press Release May 31, 2023 Abata Therapeutics Announces the Appointment of Leonard Dragone, M.D., Ph.D., as Chief Medical Officer Press Release April 20, 2023 We Now Know the Enemy: A Conversation with Richard Ransohoff, M.D. Featuring John Maraganore, Ph.D. Abata Video April 10, 2023 Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity Trends in Immunology March 30, 2023 Load More
